Potential for metalloproteinase inhibitors in cancer therapy Robert Carlson Newsletter Article 15 February 2013 Pages: 3 - 4
Further support for not using cefalosporins in severe pneumonia Newsletter Article 15 February 2013 Pages: 4 - 4
Problem of bacterial resistance clear - now it’s time to solve it Newsletter Article 15 February 2013 Pages: 5 - 5
Nortriptyline a cost-effective alternative in major depression Newsletter Article 15 February 2013 Pages: 6 - 6
Rotavirus vaccination could save millions in Finland Newsletter Article 15 February 2013 Pages: 6 - 6
Beneficial effects of roquinimex in type 1 juvenile diabetes Newsletter Article 15 February 2013 Pages: 8 - 8
Dawn of a new era with substance P antagonists in depression? Wayne Elwood Newsletter Article 15 February 2013 Pages: 9 - 10
Consider combined pneumococcal vaccination in sickle cell disease Newsletter Article 15 February 2013 Pages: 10 - 10
Tamoxifen may prevent bone fractures in the elderly Newsletter Article 15 February 2013 Pages: 11 - 11
Prophylaxis reduces incidence of active TB in HIV infection Newsletter Article 15 February 2013 Pages: 11 - 11
Estrogen replacement beneficial in postmenopausal angioplasty Newsletter Article 15 February 2013 Pages: 14 - 14
Should heparin be used routinely after uncomplicated PTCA? Newsletter Article 15 February 2013 Pages: 14 - 14
Intensive CEF regimen superior in premenopausal breast cancer Newsletter Article 15 February 2013 Pages: 16 - 16
Testosterone patch may help women with AIDS wasting syndrome Newsletter Article 15 February 2013 Pages: 16 - 16
Study of tamoxifen and concomitant HRT for women warranted Newsletter Article 15 February 2013 Pages: 17 - 17
Various β-blockers improve ejection fraction in heart failure Newsletter Article 15 February 2013 Pages: 17 - 17
Effective anticoagulation achieved with SC heparin in DVT Newsletter Article 15 February 2013 Pages: 18 - 18
Antiparasitics beneficial in AIDS-associated cryptosporidiosis Newsletter Article 15 February 2013 Pages: 19 - 19
Methotrexate a ‘disease modifying’ agent in juvenile RA? Newsletter Article 15 February 2013 Pages: 19 - 19
Activity of soluble insulin affected by administration route Newsletter Article 15 February 2013 Pages: 20 - 20
No congenital abnormalities with artemesinin derivatives in pregnancy Newsletter Article 15 February 2013 Pages: 21 - 21
Safety of somatropin in children with neurofibromatosis reassuring Newsletter Article 15 February 2013 Pages: 22 - 22
Labelling changes for anti-HIV drugs in Europe and the US Newsletter Article 15 February 2013 Pages: 22 - 22
